B Ackerson
B Ackerson
Assistant Clinical Professor Pediatrics, UCLA School of Medicine and Research and Evaluation, Kaiser
Verified email at
Cited by
Cited by
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
SY Tartof, JM Slezak, H Fischer, V Hong, BK Ackerson, ON Ranasinghe, ...
The Lancet 398 (10309), 1407-1416, 2021
Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization
SY Tartof, L Qian, V Hong, R Wei, RF Nadjafi, H Fischer, Z Li, SF Shaw, ...
Annals of internal medicine 173 (10), 773-781, 2020
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
HF Tseng, BK Ackerson, Y Luo, LS Sy, CA Talarico, Y Tian, KJ Bruxvoort, ...
Nature medicine 28 (5), 1063-1071, 2022
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine
C Chao, NP Klein, CM Velicer, LS Sy, JM Slezak, H Takhar, B Ackerson, ...
Journal of internal medicine 271 (2), 193-203, 2012
Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults
B Ackerson, HF Tseng, LS Sy, Z Solano, J Slezak, Y Luo, CA Fischetti, ...
Clinical Infectious Diseases 69 (2), 197-203, 2019
Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study
KJ Bruxvoort, LS Sy, L Qian, BK Ackerson, Y Luo, GS Lee, Y Tian, ...
Bmj 375, 2021
Safety of quadrivalent human papillomavirus vaccine administered routinely to females
NP Klein, J Hansen, C Chao, C Velicer, M Emery, J Slezak, N Lewis, ...
Archives of pediatrics & adolescent medicine 166 (12), 1140-1148, 2012
Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting
SJ Jacobsen, BK Ackerson, LS Sy, TN Tran, TL Jones, JF Yao, F Xie, ...
Vaccine 27 (34), 4656-4661, 2009
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative …
SY Tartof, JM Slezak, L Puzniak, V Hong, F Xie, BK Ackerson, SR Valluri, ...
The Lancet Respiratory Medicine 10 (7), 689-699, 2022
Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: a retrospective cohort study
SY Tartof, JM Slezak, L Puzniak, V Hong, TB Frankland, BK Ackerson, ...
The Lancet Regional Health–Americas 9, 2022
Pediatric vaccination during the COVID-19 pandemic
BK Ackerson, LS Sy, SC Glenn, L Qian, CH Park, RJ Riewerts, ...
Pediatrics 148 (1), 2021
Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study
KJ Bruxvoort, LS Sy, L Qian, BK Ackerson, Y Luo, GS Lee, Y Tian, ...
The Lancet Regional Health–Americas 6, 2022
The epidemiology of herpes zoster in immunocompetent, unvaccinated adults≥ 50 years old: incidence, complications, hospitalization, mortality, and recurrence
HF Tseng, K Bruxvoort, B Ackerson, Y Luo, H Tanenbaum, Y Tian, ...
The Journal of infectious diseases 222 (5), 798-806, 2020
Severe morbidity and short-and mid-to long-term mortality in older adults hospitalized with respiratory syncytial virus infection
HF Tseng, LS Sy, B Ackerson, Z Solano, J Slezak, Y Luo, CA Fischetti, ...
The Journal of Infectious Diseases 222 (8), 1298-1310, 2020
Effectiveness and safety of an Haemophilus type b conjugate vaccine (PRP-T) in young infants
CM Vadheim
Pediatrics 92 (2), 271-279, 1993
Hospitalization and emergency department encounters for COVID-19 after paxlovid treatment—California, December 2021–May 2022
DE Malden
MMWR. Morbidity and mortality weekly report 71, 2022
Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients
J Slezak, K Bruxvoort, H Fischer, B Broder, B Ackerson, S Tartof
Clinical Microbiology and Infection 27 (12), 1860. e7-1860. e10, 2021
Eradication of Haemophilus influenzae Type b Disease in Southern California
CM Vadheim
Arch Pediatr Adolesc Med 148 (1), 51-56, 1994
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA. 1, BA. 2, BA. 2.12. 1, BA. 4, and BA. 5
HF Tseng, BK Ackerson, KJ Bruxvoort, LS Sy, JE Tubert, GS Lee, JH Ku, ...
Nature Communications 14 (1), 189, 2023
BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA. 4 and BA. 5
SY Tartof, JM Slezak, L Puzniak, V Hong, TB Frankland, BK Ackerson, ...
The Lancet Infectious Diseases 22 (12), 1663-1665, 2022
The system can't perform the operation now. Try again later.
Articles 1–20